Executive Summary
The September 1, 2026 batch of 23 filings reveals a dominant theme of passive institutional positioning, with the most significant activist event being a decisive legal victory for ATG Capital against Empery Digital Inc., creating a high-conviction catalyst.
A notable cluster of seven separate filings for Universe Pharmaceuticals INC reveals a fragmented ownership structure with multiple 9-10% passive holders, suggesting a potential hidden control structure or coordinated accumulation that warrants close monitoring. The OrthoPediatrics Corp filing shows a major activist (Squadron Capital) actively reducing its 25% stake to raise capital, creating a persistent overhang. Insider activity is minimal across the batch, with the most material signal being the complete exit of Advent International from NCS Multistage Holdings. The period-over-period data is limited in these initial ownership filings, but the transaction details and forward-looking legal catalysts provide actionable intelligence. The overall sentiment is neutral with one high-conviction mixed (bullish) signal from the Empery Digital court ruling. The key takeaway is that while most filings are passive, the Empery Digital situation and the Universe Pharmaceuticals ownership puzzle offer the most alpha generation potential.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Schedule 13D · Schedule 13G
Tracking the trend? Catch up on the prior US Activist Hedge Fund Institutional SEC 13D 13G digest from August 24, 2026.
Investment Signals (10)
- Empery Digital Inc. (ATGC) ↓ (BULLISH)▲
Delaware court ruled board breached fiduciary duties by rejecting ATG Capital's director nominees; ATG Fund won the right to have its nominees stand for election at the annual meeting. ATG has also closed out its Bitcoin short positions, removing a potential conflict. This is a high-conviction activist catalyst with a clear path to board representation.
-
Squadron Capital, holding 25.1%, sold 375,131 shares (approx. 1.5% of the company) over 7 trading days at $23-$26 to raise capital for other portfolio businesses. This creates a persistent selling overhang but also signals Squadron's commitment to the OrthoPediatrics thesis as they maintain a massive stake. [NEUTRAL/BEARISH]
- Universe Pharmaceuticals (UPC)▲
Seven separate Schedule 13G filings from different individuals/BVI entities each disclose 9.3% to 18.3% passive stakes, totaling over 77% of the company's Class A shares. The filings are all dated July 27, 2026, and filed on September 1, 2026. This highly unusual concentration of passive stakes from separate parties suggests either a coordinated group or a hidden control structure. [BULLISH for investigation]
- New Pacific Metals Corp (NEWP) ↓ (BULLISH)▲
Helikon Investments disclosed a 10.68% passive stake (19.8M shares). Helikon is a UK FCA-regulated asset manager. A 10%+ passive stake in a metals company signals strong institutional conviction in the company's asset value, especially given the current commodity cycle.
- Rush Street Interactive (RSI) (BULLISH)▲
Divisadero Street Capital Management disclosed a new 6.2% passive stake (7.18M shares). A new, meaningful position in a growing online gaming company by a dedicated investment manager is a positive signal of institutional interest.
- NCS Multistage Holdings (NCSM) (BEARISH)▲
Advent International, a major private equity firm, has completely exited its position, dropping from a prior stake to zero shares. This is a definitive negative signal from a sophisticated institutional investor who likely had a full investment cycle view.
- Freenome (Perceptive Capital Solutions) (BULLISH)▲
Roche Holdings disclosed a 17.4% passive stake (18.7M shares) in this diagnostics company. A strategic investment from a global pharma giant like Roche provides a strong validation of Freenome's technology and potential, acting as a 'smart money' signal.
- Trilogy Metals Inc. (TMQ) ↓ (BULLISH)▲
South32 agreed to sell 8.2M shares (approx. 4.7% of the company) to the U.S. Department of Defense in a private transaction. A DoD investment is a powerful strategic catalyst, signaling national security interest in the company's assets (likely copper/zinc for Alaska).
- Concentra Group Holdings (CON) (NEUTRAL)▲
Robert Ortenzio's filing was a purely technical correction (administrative error in share count), with no change in economic exposure. This is a non-event and should be ignored.
-
Amit Agarwal disclosed a new 7.61% passive stake. A new meaningful position from a private investor can be a signal of undervaluation, but given the passive nature, it lacks the urgency of an activist filing. [NEUTRAL/BULLISH]
Risk Flags (8)
- OrthoPediatrics Corp (KIDS) / Selling Overhang↓ [HIGH RISK]▼
Squadron Capital's ongoing open-market sales (375k shares in one week) to raise capital for other portfolio businesses creates a persistent and unpredictable selling overhang that could suppress the stock price.
- Universe Pharmaceuticals (UPC) / Hidden Control Risk [HIGH RISK]▼
The simultaneous filing of seven separate 9-18% passive stakes by different BVI entities and Chinese nationals, all dated July 27, 2026, is highly anomalous. This could indicate a group acting in concert to circumvent 13D filing requirements, posing a significant governance and regulatory risk.
- Empery Digital Inc. / Board Conflict↓ [HIGH RISK]▼
The Delaware court found the Board breached its fiduciary duties. This indicates a deeply entrenched and potentially hostile board that may take further actions to resist shareholder input, creating ongoing legal and operational risk.
- NCS Multistage Holdings (NCSM) / Complete Exit by PE [HIGH RISK]▼
Advent International's complete exit is a strong negative signal. PE firms typically exit over time, and a clean exit to zero suggests a lack of confidence in near-term value creation or a need to redeploy capital away from the sector.
- Nutra Pharma Corp (NPHC) / Gift of Control↓ [MEDIUM RISK]▼
Pure Raw Supplies LLC acquired 100% of the Series B Preferred Shares (which likely carry significant voting control) via a gift. The opaque nature of the transaction and the lack of disclosed plans for the company create uncertainty and risk for minority shareholders.
- Zeta Network Group (ZNB) / Filing Error↓ [LOW RISK]▼
L1 Capital had to correct a prior filing that erroneously reported 0 shares. While corrected, this indicates a lack of internal controls or administrative sloppiness in reporting, which can be a red flag for investors tracking ownership.
- Fortress Biotech (FBIO) / Low Conviction Signal [LOW RISK]▼
Millennium Management's 5.3% stake is a passive filing with no shared voting or dispositive power reported. This is a low-conviction signal from a multi-manager platform and could be a small, quickly reversible position.
- Bluemount Holdings / Opaque Structure↓ [LOW RISK]▼
Luk Tung Lam's ownership is through a complex chain of entities (WI Holdings, Bluemount Group). The filing states she has no intention to influence control, but the opaque structure makes it difficult to assess true intentions.
Opportunities (8)
- Empery Digital Inc. (ATGC) / Activist Catalyst↓ (HIGH OPPORTUNITY)◆
The court ruling is a clear win for ATG Capital. The opportunity is to buy ahead of the annual meeting where ATG's nominees will be on the ballot. A successful board challenge could unlock significant value. The removal of the Bitcoin short position also de-risks the thesis.
- Trilogy Metals Inc. (TMQ) / U.S. DoD Strategic Investment↓ (HIGH OPPORTUNITY)◆
The U.S. Department of Defense buying a significant stake from South32 is a massive strategic validation. This de-risks the project from a permitting/funding perspective and signals the assets are critical for national security. This is a powerful catalyst for a junior miner.
- Freenome (Perceptive Capital) / Roche Strategic Stake (HIGH OPPORTUNITY)◆
Roche's 17.4% passive stake is a strong endorsement of Freenome's multi-cancer early detection technology. This could be a precursor to a deeper partnership or acquisition. The stock is likely undervalued relative to the strategic premium a pharma giant sees.
- Universe Pharmaceuticals (UPC) / Ownership Puzzle (MEDIUM OPPORTUNITY)◆
The concentration of 77%+ of shares in seven 'passive' holders is a puzzle. If these parties are acting in concert, a 13D filing or a takeover bid could be imminent. The opportunity is to investigate and potentially front-run a consolidation event.
- Rush Street Interactive (RSI) / New Institutional Interest (MEDIUM OPPORTUNITY)◆
A new 6.2% stake from Divisadero Street Capital is a fresh vote of confidence in the iGaming/sports betting sector. RSI is a well-run operator, and new institutional interest at current levels could signal a bottom or a growth re-rating.
- New Pacific Metals Corp (NEWP) / Institutional Conviction↓ (MEDIUM OPPORTUNITY)◆
Helikon's 10.68% stake is a large, concentrated bet on a silver developer. This signals deep conviction in the asset's value and management's ability to execute. For investors bullish on silver, this is a strong co-investment signal.
- biote Corp. (BTMD) / New Insider-Like Stake↓ (LOW OPPORTUNITY)◆
Amit Agarwal's 7.61% stake is a new position. While passive, a large individual investor taking a stake in a niche hormone therapy company could signal an undervalued asset with a clear growth path.
- Rainier Acquisition Corp (RNER) / SPAC Arbitrage↓ (LOW OPPORTUNITY)◆
MMCAP's 5.2% stake in a SPAC is a typical arbitrage play. The opportunity is to track the SPAC's search for a target. A high-quality target announcement could lead to a significant re-rating.
Sector Themes (5)
- Concentrated Passive Ownership in Micro-Caps◆
The Universe Pharmaceuticals filings (7 filings for ~77% ownership) and the OrthoPediatrics filing (25% holder) highlight a theme of extreme ownership concentration in micro-cap stocks. This creates binary outcomes: either a catalyst for a take-private or a liquidity trap for minority holders.
- Strategic vs. Financial Investing in Commodities◆
The Trilogy Metals (DoD) and New Pacific Metals (Helikon) filings show a divergence in capital sources for the metals & mining sector. Government/strategic investment (DoD) provides a different, more stable catalyst than financial investor conviction. Both are bullish but for different risk profiles.
- Biotech/Diagnostics Validation via Strategic Stakes◆
Roche's 17.4% stake in Freenome is a textbook example of 'smart money' validating a platform. This theme suggests that large pharma is actively placing bets on early-stage diagnostics, providing a floor for valuations and a potential M&A premium for companies with strong data.
- Activist Legal Victories as Catalysts◆
The Empery Digital ruling is a powerful reminder that legal action can be a high-conviction catalyst. When a court finds a board breached its fiduciary duties, it creates a clear path for change and often leads to a settlement or a successful proxy fight, creating alpha for event-driven investors.
- The 'Passive' Filing Anomaly◆
The sheer volume of Schedule 13G filings (passive intent) versus 13D (active intent) in this batch (22 vs 1) underscores the current market environment. However, the anomalous nature of the Universe Pharmaceuticals filings suggests that some 'passive' filings may be masking more active intentions, requiring deeper scrutiny.
Watch List (8)
-
Watch for the date of the annual meeting where ATG Capital's nominees will be on the ballot. Monitor for any settlement or further legal action from the board. The removal of the Bitcoin short is a key de-risking event.
- Universe Pharmaceuticals (UPC)👁
Monitor for any subsequent Schedule 13D filings from the group of seven holders, which would confirm they are acting in concert. Also watch for any corporate actions (merger, tender offer) from the company.
-
Monitor Squadron Capital's 13D filings for any further sales. A slowdown in selling would be a positive signal. Also watch for any insider buying from management to offset the overhang.
-
Watch for the closing of the DoD transaction and any subsequent announcements regarding project funding, permitting, or offtake agreements. The DoD's involvement is a major catalyst to track.
- NCS Multistage Holdings (NCSM)👁
Monitor for any insider buying following Advent's complete exit. If management does not step in to buy, it confirms the negative signal. Also watch for any strategic alternatives announcement.
- Freenome (Perceptive Capital Solutions)👁
Watch for any increase in Roche's stake or a transition from a 13G to a 13D, which would signal a move towards a more active or strategic role, potentially a takeover.
- Rush Street Interactive (RSI)👁
Monitor Divisadero Street Capital's next 13F filing to see if the position was increased or decreased. A new position is a good start; an increase would be a stronger signal.
- New ERA Energy & Digital (NUAIW)👁
Monitor for any further filings from KCM Capital. A 5.1% stake is just above the threshold. An increase would signal growing conviction in the company's pivot to energy and digital assets.
Filing Analyses
(23)
01-09-2026
Squadron Capital LLC and affiliates filed Amendment No. 3 to Schedule 13D, disclosing aggregate beneficial ownership of approximately 25.1% of OrthoPediatrics Corp. common stock as of September 1, 2026. The filing details a series of open-market sales by Squadron Capital LLC between August 24 and September 1, 2026, totaling 375,131 shares, with weighted average prices ranging from $23.04 to $25.75, to raise capital for other portfolio businesses. Despite the sales, the group's ownership remains substantial, with David R. Pelizzon holding the largest individual stake at 25.2%.
- · The Schedule 13D was originally filed on March 18, 2021; this is Amendment No. 3.
- · David R. Pelizzon directly holds 44,384 shares, including 17,959 restricted shares that he can vote but cannot transfer until vesting.
- · Jennifer N. Pritzker is deemed to beneficially own shares held by the Pritzker Military Museum and Library (500 shares), Tawani Foundation (1,300 shares), Pritzker Military Foundation (1,300 shares), and her spouse (707 shares).
- · Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC and its managing committee consists of Mary Falcon, David Pelizzon, and Michelle Nakfoor.
- · The sales were undertaken to provide additional capital for Squadron Capital LLC's other portfolio businesses.
01-09-2026
Luk Tung Lam filed a Schedule 13G/A with the SEC on September 1, 2026, disclosing beneficial ownership of 2,573,872 Class B ordinary shares of Bluemount Holdings Ltd, representing 18.37% of the class. The filing is an amendment to a prior 13G and indicates Ms. Luk acquired 100% of WI Holdings Limited and 40% of Bluemount Group Limited, through which she is deemed to own the shares. She states she has no intention to influence or control the issuer.
- · The filing is an amendment to a prior Schedule 13G, filed under Rule 13d-1(d).
- · Luk Tung Lam's address is No. 29 Borthwick Drive, Singapore 559532.
- · The issuer's address is Room 1007, Capital Centre, 151 Gloucester Road, Wanchai, Hong Kong.
- · The filing date is September 1, 2026, and the event date is April 7, 2026.
01-09-2026
L1 Capital Global Opportunities Master Fund, Ltd. filed an amended Schedule 13G/A with the SEC on September 1, 2026, correcting a prior filing error that had reported 0 shares. The fund now discloses beneficial ownership of 538,443 Class A Ordinary Shares of Zeta Network Group (ZNB), representing 9.99% of the 4,862,965 shares outstanding as of August 31, 2026. The holding includes shares, convertible notes, and warrants, with additional warrants for 435,286 shares excluded due to a beneficial ownership limitation.
- · The amendment corrects a scrivener's error in the prior Schedule 13G/A filed August 14, 2026, which inadvertently reported 0 Class A Ordinary Shares.
- · The beneficial ownership includes shares from direct holdings, convertible note conversion, and three tranches of warrants (February 2025, September 2025, March 2026).
- · Warrants for 435,286 additional shares purchased in March 2026 are excluded from the reported total due to a 9.99% beneficial ownership limitation.
- · David Feldman and Joel Arber, as directors of the fund, may be deemed to beneficially own the securities but disclaim beneficial ownership for all other purposes.
- · The filing certifies the securities were not acquired with the purpose or effect of changing or influencing control of the issuer.
01-09-2026
Robert A. Ortenzio filed Amendment No. 4 to Schedule 13D to correct an administrative error in his prior beneficial ownership disclosure for Concentra Group Holdings Parent, Inc. The amendment adjusts the reported beneficial ownership to 6,648,222 shares (5.3% of outstanding common stock), correcting the previously misstated figure. The filing is a technical correction and does not reflect any change in economic exposure or voting power.
- · The amendment corrects an inadvertent administrative error in the calculation of shares disclosed in Amendment No. 3 filed August 24, 2026.
- · The original Schedule 13D was filed on December 3, 2024.
- · Shared power includes shares held by multiple trusts: Robert A. Ortenzio Descendants Trust (882,115 shares), Rocco A. Ortenzio Separate Descendants Trust FBO Robert A. Ortenzio (503,455 shares), and three 2014 trusts for Bryan, Kevin, and Madeline Ortenzio (196,286, 196,286, and 206,286 shares respectively).
01-09-2026
Helikon Investments Ltd and Federico Riggio disclosed a 10.68% beneficial ownership stake in New Pacific Metals Corp, holding 19,779,255 common shares as of July 31, 2026. The filing is an amendment to Schedule 13G, indicating passive investment intent. The stake represents a significant minority position, but no change in control is intended.
- · Helikon Investments Ltd is a UK public limited company authorized and regulated by the Financial Conduct Authority.
- · Federico Riggio is a citizen of Italy.
- · The filing is made pursuant to Rule 13d-1(b), indicating passive investment intent.
- · The shares are held by Helikon Long Short Equity Fund Master ICAV, managed by Helikon Investments Ltd.
- · The filing date is September 1, 2026, with the ownership date as of July 31, 2026.
01-09-2026
Roche Holdings, Inc., along with affiliates Roche Finance Ltd and Roche Holding Ltd, filed a Schedule 13G disclosing beneficial ownership of 18,692,766 shares of Freenome, Inc. common stock, representing 17.4% of the 107,446,814 shares outstanding as of July 20, 2026. The filing indicates a significant passive stake by the Roche group in the medical diagnostics company, with no reported change in ownership from the prior period.
- · The filing is made under Rule 13d-1(d), indicating a passive investment intent.
- · Roche Holdings, Inc. is a wholly owned subsidiary of Roche Finance Ltd, which is wholly owned by Roche Holding Ltd.
- · The securities consist of 18,055,686 shares held by Roche Holdings, Inc. and 637,080 shares held by Roche Finance Ltd.
- · The filing date is September 1, 2026, with the ownership date as of July 20, 2026.
- · A Joint Filing Agreement was attached as Exhibit 99.1.
01-09-2026
ATG Capital Opportunities Fund LP filed Amendment No. 7 to its Schedule 13D on September 1, 2026, disclosing beneficial ownership of 4,500,000 shares (16.3%) of Empery Digital Inc. The filing reports a Delaware court ruling on August 28, 2026, which found that Empery Digital's Board breached its bylaws and fiduciary duties by rejecting ATG Fund's director nomination notice. The court declared ATG Fund's nomination valid and allowed its nominees to stand for election at the annual meeting, while also rejecting the Board's claims that ATG Fund needed to disclose a Bitcoin ETF short position or information about stockholder Tice Brown in the nomination notice.
- · The court found that the Board 'lacked contractual grounds to reject the Nomination Notice' and that the rejection was 'inequitable and constituted a breach of the directors' fiduciary duties.'
- · The court ruled that ATG Fund was not required to disclose its Bitcoin short position under the bylaws, and that ATG Fund 'could not fairly be expected to guess that the Board would interpret the Bylaws to require the disclosure of a Bitcoin short position.'
- · ATG Fund has since closed out its Bitcoin short positions and no longer holds any short positions in Bitcoin ETFs as of the filing date.
- · The court found that Tice Brown is not a participant in ATG Fund's solicitation and ATG Fund was not required to include information about him in the nomination notice.
- · No transactions in the issuer's securities were made by the reporting persons during the past 60 days.
- · The filing is Amendment No. 7 to the original Schedule 13D filed on January 26, 2026.
01-09-2026
Amit Agarwal filed a Schedule 13G/A with the SEC on September 1, 2026, disclosing beneficial ownership of 2,182,860 Class A shares of biote Corp., representing a 7.61% stake. The filing indicates the shares are held for investment purposes and not with the intent to change or influence control of the company.
- · The filing is an amendment (Schedule 13G/A) to a previous beneficial ownership report.
- · Amit Agarwal is a private investor based in Tampa, FL.
- · The filing was made under Rule 13d-1(c), indicating passive investment intent.
- · The filing date and date of change are both September 1, 2026.
01-09-2026
Xuefeng Li, through his wholly-owned entity August Luck Global Limited, disclosed beneficial ownership of 465,258 Class A ordinary shares of Universe Pharmaceuticals INC, representing a 9.29% stake as of July 27, 2026. The filing was made under Rule 13d-1(c) and certifies that the securities were not acquired with the purpose of changing or influencing control of the issuer.
- · The filing is a Schedule 13G (passive investment, not an activist filing) under Rule 13d-1(c).
- · August Luck Global Limited is a British Virgin Islands company wholly owned and controlled by Xuefeng Li.
- · The filing includes a Joint Filing Agreement between August Luck Global Limited and Xuefeng Li.
01-09-2026
Shan Xie and his wholly-owned entity Horizon Ridge Limited disclosed a 9.97% beneficial ownership stake in Universe Pharmaceuticals INC, holding 499,424 Class A ordinary shares as of July 27, 2026. The filing is a Schedule 13G, indicating passive investment intent without control influence. The stake is based on 5,008,313 Class A ordinary shares outstanding.
- · Horizon Ridge Limited is a British Virgin Islands company wholly owned and controlled by Shan Xie.
- · The filing is made under Rule 13d-1(c), confirming passive investment intent.
- · Shan Xie's address is Room 102, No. 25, Lane 1771, Hutai Road, Shanghai 200000, People's Republic of China.
01-09-2026
Shanshan Lu and her wholly-owned BVI company, Meridian Prosperous Limited, disclosed beneficial ownership of 498,922 Class A ordinary shares of Universe Pharmaceuticals INC, representing 9.96% of the class, in a Schedule 13G filed on September 1, 2026. The shares are held for investment purposes, not to influence control. This is a passive ownership disclosure with no change in control.
- · Meridian Prosperous Limited is a British Virgin Islands company wholly owned and controlled by Shanshan Lu.
- · The filing was made under Rule 13d-1(c), indicating passive investment intent.
- · The shares were acquired on July 30, 2026.
- · The filing includes a joint filing agreement between Meridian Prosperous Limited and Shanshan Lu.
01-09-2026
Lu Yang and his wholly-owned entity Clever Way Global Limited filed a Schedule 13G disclosing beneficial ownership of 498,922 Class A ordinary shares of Universe Pharmaceuticals INC, representing a 9.96% stake in the company as of July 27, 2026. The filing is a passive investment disclosure under Rule 13d-1(c), indicating the shares were not acquired to influence control of the issuer.
- · The filing is made under Rule 13d-1(c), indicating a passive investment intent.
- · Clever Way Global Limited is a British Virgin Islands company wholly owned and controlled by Lu Yang.
- · The filing date is September 1, 2026, with the ownership event date of July 27, 2026.
01-09-2026
A Schedule 13G filing reveals that Piao Ye and his wholly-owned BVI entity, Origin Force Intelligence Limited, collectively beneficially own 916,759 Class A ordinary shares of Universe Pharmaceuticals INC, representing an 18.30% stake. The filing, made under Rule 13d-1(c), indicates the shares were not acquired to change or influence control of the issuer.
- · The filing is made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934.
- · Origin Force Intelligence Limited is a British Virgin Islands company wholly owned and controlled by Piao Ye.
- · The filing includes a Joint Filing Agreement between Origin Force Intelligence Limited and Piao Ye.
- · The beneficial ownership percentage is calculated based on 5,008,313 Class A ordinary shares outstanding as of July 27, 2026.
- · The filing certifies that the securities were not acquired or held for the purpose of changing or influencing control of the issuer.
01-09-2026
Chunhua Zheng and her wholly-owned entity Orbis BioCapital Limited disclosed beneficial ownership of 499,926 Class A ordinary shares of Universe Pharmaceuticals INC, representing a 9.98% stake as of July 27, 2026. The filing was made under Rule 13d-1(c) and certifies that the shares were not acquired with the purpose of changing or influencing control of the issuer.
- · The filing is a Schedule 13G (passive investment) under Rule 13d-1(c), indicating the shares were not acquired to influence control.
- · Orbis BioCapital Limited is a British Virgin Islands company wholly owned and controlled by Chunhua Zheng.
- · Chunhua Zheng is an individual resident in Kunming, Yunnan Province, People's Republic of China.
- · The filing includes a Joint Filing Agreement between Orbis BioCapital Limited and Chunhua Zheng.
01-09-2026
A Schedule 13G filing reveals that Xuncheng Chen, through his wholly owned entity Star Voyage International Limited, beneficially owns 497,917 Class A ordinary shares of Universe Pharmaceuticals INC, representing a 9.94% stake as of July 27, 2026. The filing is a passive investment disclosure under Rule 13d-1(c), indicating the shares were not acquired to influence control of the issuer.
- · Star Voyage International Limited is a British Virgin Islands company wholly owned and controlled by Xuncheng Chen.
- · The filing was made pursuant to Rule 13d-1(c), confirming a passive investment intent.
- · A Joint Filing Agreement was executed on September 1, 2026, between Star Voyage International Limited and Xuncheng Chen.
01-09-2026
Chengming Tang and his wholly-owned entity Whitmore Limited disclosed beneficial ownership of 499,424 Class A ordinary shares of Universe Pharmaceuticals INC, representing a 9.97% stake as of July 27, 2026. The filing was made under Rule 13d-1(c) and certifies the securities were not acquired to change or influence control of the issuer.
- · Whitmore Limited is a British Virgin Islands company wholly owned and controlled by Chengming Tang.
- · The filing was made under Rule 13d-1(c), indicating the shares were not acquired with the purpose of changing or influencing control.
- · The filing includes a Joint Filing Agreement between Whitmore Limited and Chengming Tang.
01-09-2026
Integrated Core Strategies (US) LLC, a Millennium Management entity, filed a Schedule 13G disclosing a 5.3% passive stake in Fortress Biotech, Inc. as of August 26, 2026. The filing covers 1,778,133 shares held by Integrated Core and 1,778,561 shares beneficially owned by Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander (collectively 5.3% of the class). The filers certify the shares were not acquired to change or influence control of the issuer.
- · The filing is a Schedule 13G (passive investor) rather than a 13D (activist), indicating no intent to influence control.
- · Filing date is September 1, 2026; event date for determination of beneficial ownership is August 26, 2026.
- · No shared voting or dispositive power is reported for any of the reporting persons.
- · Israel A. Englander is the sole voting trustee of the managing member of Millennium Group Management LLC.
01-09-2026
Divisadero Street Capital Management, LP and related entities filed a Schedule 13G with the SEC on September 1, 2026, disclosing beneficial ownership of 7,177,801 shares of Rush Street Interactive, Inc. Class A common stock, representing 6.2% of the outstanding shares. The filing indicates the shares are held for investment purposes and not to influence control of the company.
- · The filing is made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934.
- · Divisadero Street Capital Management, LP disclaims beneficial ownership except for its pecuniary interest.
- · The filing includes a joint filing agreement and control person identification exhibit.
01-09-2026
Advent International, L.P. and related entities filed a Schedule 13G/A with the SEC on September 1, 2026, disclosing that they no longer beneficially own any shares of NCS Multistage Holdings, Inc. common stock. The filing reports a reduction from a prior ownership position to zero shares held as of the filing date, indicating a complete exit of the investment by Advent International.
- · The filing is an amendment (Schedule 13G/A) to a prior beneficial ownership report.
- · The reporting persons include Advent International, L.P., Advent International GP, LLC, and Advent-NCS Acquisition Limited Partnership.
- · The filing was made pursuant to Rule 13d-1(d) under the Securities Exchange Act of 1934.
- · The joint filing agreement was executed on September 1, 2026.
01-09-2026
KCM Capital Inc., AMC Fund, L.P., and Kent C. McCarthy filed a Schedule 13G disclosing beneficial ownership of 5,400,000 shares of New ERA Energy & Digital, Inc. (NUAIW) common stock, representing 5.1% of the 106,559,339 shares outstanding as of August 10, 2026. The filing indicates passive investment intent under Rule 13d-1(c), with no intention to change or influence control of the issuer.
- · The filing is a Schedule 13G (passive investment) under Rule 13d-1(c), not a 13D (activist filing).
- · The issuer changed its name from New ERA Helium Inc. on December 9, 2024, and from Roth CH V Holdings, Inc. on June 25, 2024.
- · All 5,350,000 shares held by AMC Fund, L.P. are controlled by KCM Capital, Inc., which is controlled by Kent C. McCarthy.
- · The filing was made jointly by Kent C. McCarthy, KCM Capital Inc., and AMC Fund, L.P. under a Joint Filing Agreement.
01-09-2026
MMCAP International Inc. SPC and MM Asset Management Inc. filed a Schedule 13G with the SEC on September 1, 2026, disclosing beneficial ownership of 400,000 units (Class A Ordinary Shares and Redeemable Warrants) in Rainier Acquisition Corp, representing 5.2% of the 7,694,375 outstanding issuer units as of August 28, 2026. The filing indicates passive investment intent under Rule 13d-1(c), with no intention to change or influence control of the issuer.
- · The filing was made pursuant to Rule 13d-1(c), indicating passive investment intent.
- · The beneficial owners are MMCAP International Inc. SPC (Cayman Islands) and MM Asset Management Inc. (Ontario, Canada).
- · MM Asset Management Inc. is the investment manager of MMCAP International Inc. SPC, and both entities share voting and dispositive power over the 400,000 units.
- · The filing includes a Joint Filing Agreement between the two entities.
01-09-2026
Pure Raw Supplies, LLC filed a Schedule 13D with the SEC on September 1, 2026, disclosing beneficial ownership of 12,000,000 Series B Preferred Shares of Nutra Pharma Corp (NPHC), representing 100% of that class. The shares were acquired as a bona fide gift from Rik Deitsch on August 21, 2026, with no consideration paid by the reporting person. The filing indicates the shares are held for investment purposes and no plans for changes in control or other major corporate actions are currently contemplated.
- · The shares were acquired via a bona fide gift, not a purchase, and no funds were borrowed or used.
- · The reporting person has no plans or proposals that would result in any of the actions described in Item 4 of Schedule 13D (e.g., merger, sale of assets, change in board).
- · The reporting person has not been convicted in any criminal proceeding or been subject to securities-related civil judgments in the past five years.
01-09-2026
South32 Limited and its wholly-owned subsidiary South32 International Investment Holdings Pty Ltd filed an amended Schedule 13G with the SEC, disclosing beneficial ownership of 10,379,741 common shares of Trilogy Metals Inc., representing 6.01% of the outstanding shares as of August 28, 2026. The filing notes that South32 International agreed to sell 8,215,570 shares to the U.S. Department of Defense in a private transaction on the same date, reducing its stake. The filing indicates passive investment intent, with no purpose of changing or influencing control.
- · The filing is an amendment (SCHEDULE 13G/A) to a previous beneficial ownership report.
- · South32 International is a wholly-owned subsidiary of South32 Limited.
- · The transaction agreement was dated August 28, 2026, and the filing was made on September 1, 2026.
- · The filing certifies that the securities were not acquired to change or influence control of the issuer.
Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 23 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Activist Hedge Fund Institutional SEC 13D 13G
August 21, 2026
US Activist Hedge Fund Institutional SEC 13D 13G — August 21, 2026
August 20, 2026
US Activist Hedge Fund Institutional SEC 13D 13G — August 20, 2026
August 19, 2026
US Activist Hedge Fund Institutional SEC 13D 13G — August 19, 2026
August 18, 2026
US Activist Hedge Fund Institutional SEC 13D 13G — August 18, 2026
🇺🇸 More from United States
View all →August 25, 2026
US Pre-Market SEC Filings Roundup — August 25, 2026
US Pre-Market SEC Filings Roundup
August 25, 2026
US Corporate Board Director Changes SEC Filings — August 25, 2026
US Corporate Board Director Changes SEC Filings
August 25, 2026
US Merger & Acquisition SEC Filings — August 25, 2026
US Merger & Acquisition SEC Filings
August 25, 2026
USA Insider Trading Pulse — August 25, 2026
USA Insider Trading Pulse